Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-5-10
pubmed:abstractText
Multivalent dendrimeric conjugates of GPCR ligands may have increased potency or selectivity in comparison to monomeric ligands, a phenomenon that was tested in a model of cytoprotection in mouse HL-1 cardiomyocytes. Quantitative RT-PCR indicated high expression levels of endogenous A(1) and A(2A) adenosine receptors (ARs), but not of A(2B) and A(3)ARs. Activation of the heterologously expressed human A(3)AR in HL-1 cells by AR agonists significantly attenuated cell damage following 4h exposure to H(2)O(2) (750 microM) but not in untransfected cells. The A(3) agonist IB-MECA (EC(50) 3.8 microM) and the non-selective agonist NECA (EC(50) 3.9 microM) protected A(3) AR-transfected cells against H(2)O(2) in a concentration-dependent manner, as determined by lactate dehydrogenase release. A generation 5.5 PAMAM (polyamidoamine) dendrimeric conjugate of a N(6)-chain-functionalized adenosine agonist was synthesized and its mass indicated an average of 60 amide-linked nucleoside moieties out of 256 theoretical attachment sites. It non-selectively activated the A(3)AR to inhibit forskolin-stimulated cAMP formation (IC(50) 66nM) and, similarly, protected A(3)-transfected HL-1 cells from apoptosis-inducing H(2)O(2) with greater potency (IC(50) 35nM) than monomeric nucleosides. Thus, a PAMAM conjugate retained AR binding affinity and displayed greatly enhanced cardioprotective potency.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-10449539, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-10877835, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-11249876, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-12440705, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-14766671, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-15131243, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16005018, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16033270, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16290152, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16333296, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16518376, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16604184, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16876820, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-16985166, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-17016854, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-17214599, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-17216675, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-17408751, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18004403, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18050382, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18176997, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18600474, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18610944, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18636149, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18639453, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18648236, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18675812, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18828873, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-18947419, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-19242639, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-19639281, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-7675214, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-9249524, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-9364471, http://linkedlifedata.com/resource/pubmed/commentcorrection/20346920-9501201
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1873-2968
pubmed:author
pubmed:copyrightInfo
Published by Elsevier Inc.
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
188-96
pubmed:dateRevised
2011-9-29
pubmed:meshHeading
pubmed-meshheading:20346920-Adenosine, pubmed-meshheading:20346920-Adenosine-5'-(N-ethylcarboxamide), pubmed-meshheading:20346920-Animals, pubmed-meshheading:20346920-CHO Cells, pubmed-meshheading:20346920-Cell Death, pubmed-meshheading:20346920-Cells, Cultured, pubmed-meshheading:20346920-Cricetinae, pubmed-meshheading:20346920-Cricetulus, pubmed-meshheading:20346920-Cytoprotection, pubmed-meshheading:20346920-Dendrimers, pubmed-meshheading:20346920-Gene Expression Regulation, pubmed-meshheading:20346920-Humans, pubmed-meshheading:20346920-Hydrogen Peroxide, pubmed-meshheading:20346920-Mice, pubmed-meshheading:20346920-Myocytes, Cardiac, pubmed-meshheading:20346920-Oxidants, pubmed-meshheading:20346920-Protein Binding, pubmed-meshheading:20346920-Receptors, Purinergic P1, pubmed-meshheading:20346920-Transfection
pubmed:year
2010
pubmed:articleTitle
Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor.
pubmed:affiliation
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, USA.
More...